G1 Therapeutics, Inc.
Biotechnology ResearchNorth Carolina, United States51-200 Employees
G1 Therapeutics, Inc. is a wholly owned subsidiary of Pharmacosmos.
G1 Therapeutics, Inc. uses 8 technology products and services including Google Analytics, SAS, Akamai, and more. Explore G1 Therapeutics, Inc.'s tech stack below.
G1 Therapeutics, Inc. Email Formats | Percentage |
FLast@g1therapeutics.com | 94% |
FirstLast@g1therapeutics.com | 4% |
First.Last@g1therapeutics.com | 1% |
FirLast@g1therapeutics.com | 1% |
Biotechnology ResearchNorth Carolina, United States51-200 Employees
G1 Therapeutics, Inc. is a wholly owned subsidiary of Pharmacosmos.
G1 Therapeutics, Inc. has raised a total of $50M of funding over 10 rounds. Their latest funding round was raised on Nov 17, 2022 in the amount of $50M.
G1 Therapeutics, Inc.'s revenue is in the range of $10M$50M
G1 Therapeutics, Inc. has raised a total of $50M of funding over 10 rounds. Their latest funding round was raised on Nov 17, 2022 in the amount of $50M.
G1 Therapeutics, Inc.'s revenue is in the range of $10M$50M